Five-year Molecular Response and Overall Survival with First- and Second-Generation Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia in the Chronic Phase: a Prospective, Observational Study - SIMPLICITY.
Leukemia & lymphoma(2025)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要